Related Articles
Urantide decreases hepatic steatosis in rats with experimental atherosclerosis via the MAPK/Erk/JNK pathway
The peptide compound urantide regulates collagen metabolism in atherosclerotic rat hearts and inhibits the JAK2/STAT3 pathway
The urotensin II receptor antagonist, urantide, protects against atherosclerosis in rats
The urotension II antagonist SB-710411 arrests fibrosis in CCL4 cirrhotic rats
Increased expression of urotensin II and GPR14 in patients with cirrhosis and portal hypertension